The article reports on various cervical cancer vaccines. GlaxoSmithKline claimed that its Cervarix is highly immunogenic and well tolerated in women over 25 years of age. The U.S. Food and Drug Administration approved Merck's Gardasil for use in women between 9 and 26 years of age. However, ...
Cervical cancer is the most common cause of cancer-related mortality among women in Africa. Cervical cancer screening in women is associated with decreased incidence and mortality of cervical cancer. There is a dearth of recent data regarding the prevale
9-valent HPV vaccine approved for wider age range MSD China announced on Tuesday that it has received approval from China's National Medical Products Administration to extend the use of its 9-valent vaccine against HPV for females bet...
According to the CDC, the ideal age range to receive the HPV vaccine is between 11 and 12 years old. However, adolescents as young as 9 years old and adults up to age 45 may be candidates for the vaccine.3 A person's age and immune status may determine how many doses of the vaccin...
The RCS presented a nonlinear relationship between age and cervical cancer-specific mortality (p < 0.001) (Fig. 1). The plot showed a reduction trend of risk within the lower age range; the lowest risk was reached at age 35.58 years old [HR = 0.687, 95% CI (0.631, 0.749)],...
Cervical cancer is the fourth most common cancer in women worldwide. Although cytology or HPV testing is available for screening, these techniques have their drawbacks and optimal screening methods are still being developed. Here, we sought to determine
may vary in different populations.To investigate the types of HPV, age distribution, and risk factors for HPV infection in women from Santiago, Chile.We interviewed and obtained two cervical specimens from a population-based random sample of 1,038 sexually active women (age range, 15-69 years)...
In contrast, cervical cancer rates among women in the same age range decreased by 1.8% per year on average but still represents 16% of the total female cancer burden in the latest 5-year period. The age- standardised incidence of ovarian cancer among 30- to 64-year old women were ...
Methods: Between April 2010 and December 2018, 21 patients aged ≧80 years(older group:8 men and 13 women;age range, 80-90 years)who underwent laminoplasty were reviewed and compared with 23 patients aged <80 years(younger group;13 men and 10 women;age range, 42-79 years)who underwent ...
In Kenya, screening rates range between 14% and 16% for women aged between 18 and 69. In Kisumu County, facility-based reports from KHIS 2019 [4] indicated that only 5.7% of the eligible women were screened in 2019, and only 29,130 were screened in 2020. It was therefore critical to...